Wedbush Reiterates Outperform on Zura Bio, Maintains $15 Price Target
Wedbush analyst Martin Fan reiterates Zura Bio (NASDAQ: ZURA ) with a Outperform and maintains $15 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.